Michael Schmertzler sold $1.8M of PTC Therapeutics (PTCT)

Executed Aug 26, disclosed Aug 28, 2 days later.

Value, as filed

$1.8M

24,390 sh across 3 lots

Executed

Aug 26

the trade date, as filed

Disclosed

Aug 28

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Michael Schmertzler Director profile →

Michael Schmertzler (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in PTC Therapeutics, Inc. (PTCT). The largest single filing was $1.8M of PTCT (24,390 sh across 3 lots, as filed), executed Aug 26.

The name

PTCT

PTC Therapeutics, Inc. PTCT · Healthcare · 84 filings in 24 months ticker →

Healthcare · PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Michael Schmertzler in PTCT

PTCTSALE PTC Therapeutics, Inc. $126K
2,118 sh × $59.52
Exec Oct 14
Filed Oct 16 · 5:20 PM ET PTCTSALE PTC Therapeutics, Inc. $155K
2,447 sh × $63.38
Exec Oct 7
Filed Oct 9 · 5:20 PM ET PTCTSALE PTC Therapeutics, Inc. $1.3M
19,624 sh across 3 lots
Exec Sep 16
Filed Sep 18 · 5:20 PM ET PTCTSALE PTC Therapeutics, Inc. $1.3M
19,428 sh across 2 lots
Exec Sep 9
Filed Sep 11 · 5:20 PM ET PTCTSALE PTC Therapeutics, Inc. $1.8M
24,309 sh across 4 lots
Exec Aug 19
Filed Aug 21 · 5:20 PM ET